A) Market Overview:
The global meningococcal vaccines market is estimated to be valued at US$ 2,965.9 million in 2019 and is expected to exhibit a CAGR of 12.7% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
Meningococcal vaccines are designed to prevent infections caused by Neisseria meningitidis, a bacterium that can cause severe meningitis and septicemia. These vaccines provide significant advantages in terms of reducing the incidence of meningococcal diseases and their associated complications. The increasing prevalence of meningococcal infections, coupled with rising awareness about vaccination programs, is driving the demand for meningococcal vaccines worldwide. Meningococcal vaccines offer a crucial solution to the urgent need for effective prevention and control of this deadly disease.
B) Market Key Trends:
One key trend in the meningococcal vaccines market is the introduction of combination vaccines. Combination vaccines, which include multiple antigens in a single vaccine, have gained significant popularity due to their convenience and effectiveness in preventing multiple diseases. Manufacturers are increasingly focusing on developing combination vaccines that provide protection against multiple serogroups of Neisseria meningitidis. This trend is driven by the need for simplification of vaccination schedules, cost-effectiveness, and improved patient compliance. Combination vaccines not only offer protection against multiple serogroups but also reduce the number of vaccinations required, thereby making immunization programs more efficient. The introduction of combination vaccines is anticipated to drive the growth of the meningococcal vaccines market over the forecast period.
Segment Analysis:
The meningococcal vaccines market can be segmented based on type, end-user, and region. By type, the market can be divided into polysaccharide vaccines, conjugate vaccines, and combination vaccines. Among these, conjugate vaccines dominate the market segment due to their increased effectiveness and longer duration of protection. Conjugate vaccines are widely used for meningococcal disease prevention, especially in infants and young children. They offer immunity against multiple serogroups of meningococcal bacteria and have shown promising results in reducing the number of cases and related mortality rates.
By end-user, the market is segmented into hospitals, clinics, and others. Hospitals hold the largest share in the market as they are the primary healthcare facilities where meningococcal vaccinations are administered. The availability of skilled healthcare professionals, advanced infrastructure, and government initiatives supporting vaccination programs in hospitals contribute to their dominance in this segment.
Key Takeaways:
The global Meningococcal Vaccines Market Segmentation is expected to witness high growth, exhibiting a CAGR of 12.7% over the forecast period (2020-2027). Several factors are driving this growth, including increasing awareness about meningococcal diseases, rising government initiatives for vaccination programs, and growing adoption of advanced vaccines.
In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the meningococcal vaccines market. This can be attributed to a well-established healthcare infrastructure, high healthcare expenditure, and strong government initiatives promoting vaccination campaigns. Furthermore, the presence of key market players and ongoing research and development activities in this region contribute to its dominance in the market.
Key players operating in the meningococcal vaccines market include Baxter International, Inc., Biomed Pvt. Ltd., GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG, Pfizer, Inc., Sanofi SA, and Serum Institute of India Ltd. These companies are actively involved in product development, collaborations, mergers and acquisitions, and other strategic initiatives to strengthen their market presence and gain a competitive edge.
Read more @ https://www.newsanalyticspro.com/meningococcal-vaccines-market-growing-demand-for-market-growth/
Comments
0 comment